We provide you with 20 years of free, institutional-grade data for ACRV stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACRV. Explore the full financial landscape of ACRV stock.
| Reported Date | CIK | Ticker | Type |
|---|
Acrivon Therapeutics, Inc.(NASDAQ:ACRV) 
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to specific medicine by utilizing its proteomics-based patient responder identification platform, Acrivon ...
Website: https://www.acrivon.com
Founded: 2018
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about ACRV stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.